Will benefit customers of LGC and NuGEN, as it expands options to access SPET technology through SeqSNP service
Service allows customers to accelerate animal and plant breeding and bring products to market faster
Distribution agreement to supply range of state-of-the-art sonication systems for DNA fragmentation
Appointments further strengthen expertise to help drive development of its NGS products and services
Funding to develop liver targeted gene activation therapies
In recognition of medical focus to research he and his team conducted on development and standardisation of molecular diagnostics
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.